/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Angiogenic gene therapy for refractory angina: results of the epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (EXACT) phase 2 trial
Event: ESC Congress 2023
Topic: Pharmacotherapy
Session: Risk stratification and treatment options in chronic coronary syndrome
